DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Manns M, Zeuzem S, Sood A. et al
Reduced dose and duration of peginterferon alfa-2b and weight-based ribvairin in European and Asian genotype 2 and 3 chronic hepatitis C patients (REDD 2/3 trial).
J Hepatol 2009; 50: A144-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.